Exploring Machine Learning Techniques to Predict the Response to Omalizumab in Chronic Spontaneous Urticaria

Background: Omalizumab is the best treatment for patients with chronic spontaneous urticaria (CSU). Machine learning (ML) approaches can be used to predict response to therapy and the effectiveness of a treatment. No studies are available on the use of ML techniques to predict the response to Omaliz...

Descripción completa

Detalles Bibliográficos
Autores principales: Sardina, Davide Stefano, Valenti, Giuseppe, Papia, Francesco, Uasuf, Carina Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623518/
https://www.ncbi.nlm.nih.gov/pubmed/34829497
http://dx.doi.org/10.3390/diagnostics11112150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623518/
https://www.ncbi.nlm.nih.gov/pubmed/34829497
http://dx.doi.org/10.3390/diagnostics11112150

Ejemplares similares